Coeptis Therapeutics Holdings- Warrants (31/10/2025) Accounts Payable

As of the most recent data (June 2026), COEPW shows a accounts payable of $1.4M. That compares with $1M in the prior-year period — up 34.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, COEPW's accounts payable is now $1.4M (was $1M) — a 34.3% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Coeptis Therapeutics Holdings- Warrants (31/10/2025) is outperforming or lagging.

Tracking COEPW's accounts payable over time shows whether Coeptis Therapeutics Holdings- Warrants (31/10/2025) is scaling, shrinking, or reshaping that part of the business. The current reading is $1.4M That compares with $1M in the prior-year period — up 34.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has Coeptis Therapeutics Holdings- Warrants (31/10/2025)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $1.4M) with ownership activity and broader fundamentals.